Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity

Thorax

Volumn 66, Issue 5, 2011, Pages 368-374

  Lauder, Sarah N ^a   Taylor, Philip R ^a   Clark, Stephen R ^a   Evans, Rhys L ^a   Hindley, James P ^a   Smart, Kathryn ^a   Leach, Heather ^a   Kidd, Emma J ^a   Broadley, Kenneth J ^a   Jones, Simon A ^a   Wise, Matt P ^b   Godkin, Andrew J ^a   O'Donnell, Valerie ^a   Gallimore, Awen M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CELECOXIB; CYCLOOXYGENASE 2; GAMMA INTERFERON; PARACETAMOL; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION RESISTANCE; INFLAMMATORY CELL; INNATE IMMUNITY; LIVER DYSFUNCTION; LUNG DISEASE; LUNG FUNCTION; MORBIDITY; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; SEASONAL INFLUENZA; VIRAL CLEARANCE; VIRUS IMMUNITY; VIRUS LOAD;

EID: 79955023757     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.150318     Document Type: Article

References (24)

1. Murray CJ, Lopez AD, Chin B, et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006;368:2211-18. (Pubitemid 44959013)
2. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
3. Conn CA, McClellan JL, Maassab HF, et al. Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 1995;268: R78-84.
4. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 2008;172:1155-70. (Pubitemid 351671530)
5. Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008;26(Suppl 4): D59-66.
6. Perrone LA, Plowden JK, Garcia-Sastre A, et al. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008;4: e1000115.
7. Bertolini A, Ferrari A, Ottani A, et al. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006;12:250-75. (Pubitemid 46047791)
8. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2008;22:383-90. (Pubitemid 351225574)
9. Carey MA, Bradbury JA, Seubert JM, et al. Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J Immunol 2005;175:6878-84. (Pubitemid 41598933)
10. Graham NM, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, paracetamol, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis 1990;162:1277-82.
11. Prymula R, Siegrist CE, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009;374:1339-50.
12. Longhi MP, Williams A, Wise M, et al. CD59a deficiency exacerbates influenzainduced lung inflammation through complement-dependent and-independent mechanisms. Eur J Immunol 2007;37:1266-74. (Pubitemid 46925311)
13. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988;41:467-70. (Pubitemid 18098428)
14. Polakos NK, Cornejo JC, Murray DA, et al. Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol 2006;168:1169-78; quiz 1404-5.
15. Bozanich EM, Gualano RC, Zosky GR, et al. Acute Influenza A infection inducesbronchial hyper-responsiveness in mice. Respir Physiol Neurobiol 2008;162:190-6. 17.
16. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2009;362:1708-19.
17. Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2009;134:235-43.
18. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2009;181:72-9.
19. Lee SM, Cheung CY, Nicholls JM, et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 2008;198:525-35.
20. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002;360:1831-7. (Pubitemid 35449422)
21. Lee SM, Gardy JL, Cheung CY, et al. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 2009;4: e8072.
22. Zheng BJ, Chan KW, Lin YP, et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA 2008;105:8091-6.
23. Bloom ET, Babbitt JT. Prostaglandin E2, monocyte adherence and interleukin-1 in the regulation of human natural killer cell activity by monocytes. Nat Immun Cell Growth Regul 1990;9:36-48. (Pubitemid 20102166)
24. Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis 2008;8:571-6.